| Journal | Issue | Title | Abstract | File |
| REMEDIUM | No 11 (2019) | Bayer v dialoge s rossiyskimi spetsialistami zdravookhraneniya | Abstract |
 (Rus) |
| Article E. | ||||
| REMEDIUM | No 7-8 (2020) | Beyond the Future | Abstract |
(Rus) |
| Prozherina Y. | ||||
| REMEDIUM | No 1 (2024) | Bibliometric analysis of the results of intellectual activity (using the example of dissertations in psychiatry) | Abstract |
(Rus) |
| Shport S.V., Eminova V.S. | ||||
| REMEDIUM | No 12 (2019) | Big Data Analytics of EHRs: pathogenic relations of cancer with Ischaemic Heart Disease and Diabetes Mellitus | Abstract |
(Rus) |
| Kolesnichenko O.Y., Kolesnichenko Y.Y., Pulit V.V., Martynov A.V., Sotnik A.Y., Khaykina I.A., Marochkina E.B., Minushkina L.O., Pimenova K.V., Bugakova A.S., Vasilyeva E.Y., Komarov R.N., Golovanov A.V. | ||||
| REMEDIUM | No 4 (2021) | Biocompatible drugs-protectors against radiation exposure: a modern view on the problem | Abstract | |
| Khabriev R.U., Mingazova E.N., Sidorov V.V., Gureev S.A., Yusupova M.M. | ||||
| REMEDIUM | No 4 (2024) | Bioeconomical trends in modern medicine (literature review) | Abstract |
(Rus) |
| Borshchuk E.L., Bulycheva E.V., Begun D.N., Zudin A.B. | ||||
| REMEDIUM | No 3 (2021) | Biosimilars: evolution of approaches to the development, regulation, life cycle control and interchangeability management | Abstract |
(Rus) |
| Niyazov R.R., Dranitsyna M.A., Vasiliev A.N., Gavrishina E.V. | ||||
| REMEDIUM | No 2 (2021) | Biosimilars: reproduction of the clinical profile using modern biotechnology | Abstract |
(Rus) |
| Niyazov R.R., Dranitsyna M.A., Vasiliev A.N., Gavrishina E.V. | ||||
| REMEDIUM | No 1-2 (2019) | Blood glucose meters and test strips: pharmacy market | Abstract |
(Rus) |
| Prozherina J. | ||||
| REMEDIUM | No 6 (2018) | Brief review of judicial practice in the sphere of manufacturing and handling medical products for the period from february to May 2018 | Abstract |
(Rus) |
| Borzova M. | ||||
| REMEDIUM | No 1 (2022) | Bringing registration dossiers in line with the requirements of the EAEU is the number one priority for pharmaceutical industry enterprises | Abstract | |
| Plotnikov A.V., Koroleva T.A. | ||||
| REMEDIUM | No 9 (2020) | Bronchial asthma: fundamental changes in the new GINA guidelines(2019) | Abstract |
(Rus) |
| Vodovozov A. | ||||
| REMEDIUM | No 13S (2018) | Budget segment (exclusive of subsidized drug coverage) | Abstract |
(Rus) |
| Article E. | ||||
| REMEDIUM | No 12 (2019) | Budget segment of the PD market in Russia: results for 9 months of 2019 | Abstract |
(Rus) |
| Prozherina Y. | ||||
| REMEDIUM | No 4 (2021) | Building a logical-semantic model of the choice of fixed combinations of drugs for treatment of hypertension | Abstract | |
| Ibragimova G.Y., Fedotova A.A., Iksanova G.R., Khasanova R.Y., Vasilchenko K.A. | ||||
| REMEDIUM | No 4 (2018) | Business activity of medical industry enterprises: net profit rating 2016 | Abstract |
(Rus) |
| Romanova S. | ||||
| REMEDIUM | No 4 (2018) | Business efficiency of enterprises in the pharmaceutical industry: net profit rating for 2016 | Abstract |
(Rus) |
| Romanova S. | ||||
| REMEDIUM | No 4 (2018) | Business efficiency of enterprises in the pharmaceutical industry: net profit rating for 2016 | Abstract |
(Rus) |
| Romanova S. | ||||
| REMEDIUM | No 5 (2018) | Business efficiency of enterprises in the pharmaceutical sector: 2016 net profit rating | Abstract |
(Rus) |
| Romanova S. | ||||
| REMEDIUM | No 3 (2018) | Business efficiency of enterprises in the pharmaceutical sector: 2016 return on investment rating | Abstract |
(Rus) |
| Romanova S. | ||||
| REMEDIUM | No 1-2 (2018) | Business efficiency of enterprises in the pharmaceutical sector: sales profit rating for 2016 | Abstract |
(Rus) |
| Romanova S. | ||||
| REMEDIUM | No 6 (2018) | Business efficiency of enterprises in the pharmaceutical sector: stock turnover rating for 2016 | Abstract |
(Rus) |
| Romanova S. | ||||
| REMEDIUM | No 1-2 (2018) | Business performance of pharma industry enterprises: 2016 equity turnover rating | Abstract |
(Rus) |
| Romanova S. | ||||
| REMEDIUM | No 13S (2018) | Cerebrolysin® is currently enjoying a new lease on life | Abstract |
(Rus) |
| Prozherina J. | ||||
| REMEDIUM | No 4 (2019) | CHALLENGES AND ISSUES IN OPERATING PERSONNEL MANAGEMENT DURING THE IMPLEMENTATION OF PHARMACEUTICAL QUALITY SYSTEM | Abstract |
(Rus) |
| SMIRNOV V.A., GORYACHKIN V.V., SHESTAKOV V.N., ABRAMOVICH R.A. | ||||
| 76 - 100 of 832 Items | << < 1 2 3 4 5 6 7 8 9 10 > >> | |||